Ozempic, Wegovy among drugs selected for Medicare's price negotiations
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.
The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...
The first study to assess how weight-loss drugs affect the whole of human health has discovered an "eye-opening" impact on ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...
Biden administration says popular weight loss drugs have been added to Medicare’s list of medications that will be negotiated ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback